Filed: 2/14/2025ACC: 0000895345-25-000069
📋 What this filing means
ALERCE INVESTMENT MANAGEMENT, L.P. filed this quarterly 13F‑HR report disclosing 5 equity positions with a total reported market value of $56.80M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
5
Positions
$56.80M
Total AUM (reported)
13.77M
Total Shares
Allocation by class
COM$48.92M86.1%
SPONSORED ADS$4.09M7.2%
COM CL A NEW$3.80M6.7%
Portfolio Concentration
Top 3$53.00M93.3%
4–10$3.80M6.7%
Top 3 weight
93.3%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 13.77M
Sole
Full voting authority
13.77M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole5
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings5
Rows:
ANNEXON INC
SOLEShares7.41M
TypeSH
Market value$37.99M
66.89%
Sole
7.41M
Shared
0.00
None
0.00
AKEBIA THERAPEUTICS INC
SOLEShares5.75M
TypeSH
Market value$10.92M
19.23%
Sole
5.75M
Shared
0.00
None
0.00
VERONA PHARMA PLC
SOLEShares88K
TypeSH
Market value$4.09M
7.19%
Sole
88K
Shared
0.00
None
0.00
AMERICAN WELL CORP
SOLEShares523.78K
TypeSH
Market value$3.80M
6.69%
Sole
523.78K
Shared
0.00
None
0.00
AADI BIOSCIENCE INC
SOLEShares659.00
TypeSH
Market value$2.1K
<0.01%
Sole
659.00
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
ANNEXON INCSOLE | COM | 7.41M | SH | $37.99M 66.89% | 7.41M | 0.00 | 0.00 |
AKEBIA THERAPEUTICS INCSOLE | COM | 5.75M | SH | $10.92M 19.23% | 5.75M | 0.00 | 0.00 |
VERONA PHARMA PLCSOLE | SPONSORED ADS | 88K | SH | $4.09M 7.19% | 88K | 0.00 | 0.00 |
AMERICAN WELL CORPSOLE | COM CL A NEW | 523.78K | SH | $3.80M 6.69% | 523.78K | 0.00 | 0.00 |
AADI BIOSCIENCE INCSOLE | COM | 659.00 | SH | $2.1K <0.01% | 659.00 | 0.00 | 0.00 |